Lifeboat Foundation

Run by the team at orchestration, AI, and automation platform Tines, the Tines library contains pre-built workflows shared by real security practitioners from across the community, all of which are free to import and deploy via the Community Edition of the platform.

Their bi-annual “You Did What with Tines?!” competition highlights some of the most interesting workflows submitted by their users, many of which demonstrate practical applications of large language models (LLMs) to address complex challenges in security operations.

One recent winner is a workflow designed to automate CrowdStrike RFM reporting. Developed by Tom Power, a security analyst at The University of British Columbia, it uses orchestration, AI and automation to reduce the time spent on manual reporting.

Crafting a unique and promising research hypothesis is a fundamental skill for any scientist. It can also be time consuming: New PhD candidates might spend the first year of their program trying to decide exactly what to explore in their experiments. What if artificial intelligence could help?

MIT researchers have created a way to autonomously generate and evaluate promising research hypotheses across fields, through human-AI collaboration. In a new paper, they describe how they used this framework to create evidence-driven hypotheses that align with unmet research needs in the field of biologically inspired materials.

Published Wednesday in Advanced Materials, the study was co-authored by Alireza Ghafarollahi, a postdoc in the Laboratory for Atomistic and Molecular Mechanics (LAMM), and Markus Buehler, the Jerry McAfee Professor in Engineering in MIT’s departments of Civil and Environmental Engineering and of Mechanical Engineering and director of LAMM.

Research published in The American Journal of Human Genetics has identified a previously unknown genetic link to autism spectrum disorder (ASD). The study found that variants in the DDX53 gene contribute to ASD, providing new insights into the genetic underpinnings of the condition.

ASD, which affects more males than females, encompasses a group of neurodevelopmental conditions that result in challenges related to communication, social understanding and behavior. While DDX53, located on the X chromosome, is known to play a role in brain development and function, it was not previously definitively associated with autism.

In the study, researchers from The Hospital for Sick Children (SickKids) in Canada and the Istituto Giannina Gaslini in Italy clinically tested 10 individuals with ASD from eight different families and found that variants in the DDX53 gene were maternally inherited and present in these individuals. Notably, the majority were male, highlighting the gene’s potential role in the male predominance observed in ASD.

Scientists teasing through six billion particle smashups detect roughly 16 “antihyperhydrogen-4” particles.

FOR IMMEDIATE RELEASE

“High-Speed Sequential DNA Computing Using a Solid-State DNA Origami Register” ACS Central Science

DNA stores the instructions for life and, along with enzymes and other molecules, computes everything from hair color to risk of developing diseases. Harnessing that prowess and immense storage capacity could lead to DNA-based computers that are faster and smaller than today’s silicon-based versions. As a step toward that goal, researchers report in ACS Central Science a fast, sequential DNA computing method that is also rewritable — just like current computers.

The data shows that RNA interacts with a mitochondrial protein complex to trigger immune response pathways when viral RNA is present.

Penn Engineers have modified lipid nanoparticles (LNPs)—the revolutionary technology behind the COVID-19 mRNA vaccines—to not only cross the blood-brain barrier (BBB) but also to target specific types of cells, including neurons. This breakthrough marks a significant step toward potential next-generation treatments for neurological diseases like Alzheimer’s and Parkinson’s.

In a new paper in Nano Letters, the researchers demonstrate how peptides —short strings of amino acids —can serve as precise targeting molecules, enabling LNPs to deliver mRNA specifically to the endothelial cells that line the blood vessels of the brain, as well as neurons.

This represents an important advance in delivering mRNA to the cell types that would be key in treating neurodegenerative diseases; any such treatments will need to ensure that mRNA arrives at the correct location. Previous work by the same researchers proved that LNPs can cross the BBB and deliver mRNA to the brain, but did not attempt to control which cells the LNPs targeted.

There is more research than ever focused on reflecting sunlight away from the planet to cool the climate – but there are still far more questions than answers about the effects.

By James Dinneen

To create cultured LMNs that replicate ALS neuron physiology and function, the Japanese team combined a small molecule-based approach with transcription factor transduction. The researchers achieved 80% induction efficiency of LMNs within just two weeks compared with conventional methods.

The resulting LMNs were found to have replicated ALS-specific pathologies, such as the abnormal aggregation of TDP-43 and FUS proteins. The team confirmed functionality of the LMNs using a multi-electrode array (MEA) system to measure firing activity and network activity, which were found to be similar to mature neurons.

Further analysis of the cultured LMNs showed that in addition to maintaining ALS cellular markers, the LMNs had reduced survival rates compared with healthy cells, mimicking ALS motor neuron responses.